Superior energy-related safety through selective tissue targeting

The Shape of future

The shape of the future.

The FARAPULSE Pulsed Field Ablation System produces durable, effective lesions and minimises collateral damage risks associated with thermal energy sources.¹ Validated more than any other pulsed field ablation (PFA) system, FARAPULSE PFA is pioneering possibilities for the future of tissue-selective ablation.

Tissue-selective ablation.

Unlike thermal energy applications, the FARAPULSE Pulsed Field Ablation System uses a proprietary waveform to ablate cardiomyocytes which have lower electric field damage thresholds while preserving surrounding tissue — despite exposure to the field.²

Tissue Selective ablation

Discover more about FARAPULSE PFA lesion science from Ass. Prof. Kars Neven.


Proven procedural prescription for successful PVI.

Pulsed field ablation is highly parameter-dependent, and slight variations in polarity, waveform, catheter electrodes, pulse characteristics, or applications can be the difference between acute or chronic success⁴. The FARAPULSE Pulsed Field Ablation System was optimised through years of iterations to define and validate the dose with catheter, waveform, and application sequence.

Pulmonary Vein Durability on Remapping¹
Prospective Remaps at 93 ± 30 days

Panoramic procedure view of ablation using FARAPULSE PFA System

All three cohorts showed 100% acute PVs isolated, though lesion durability varied significantly at remap (~3 months). Acute isolation alone is not enough to assure durable lesions — remapping data validates the FARAPULSE Pulsed Field Ablation System’s optimal dosing and applications for long-term success.¹

"Pulsed field ablation offers [an] effective method for atrial fibrillation ablation, with a reduced risk of collateral damage...
I would strongly recommend having PFA in the EP toolbox."

Prof. Gabor Szeplaki

 Prof. Gábor Széplaki​
Mater Private Hospital, Dublin​

Learn about PFA from the experts.​

Discover how FARAPULSE PFA increased procedure volumes and predictability for Prof. Szeplaki and team. 

Interested in hearing an expert’s thoughts on lesion creation with FARAPULSE PFA? Listen to what Prof. Tobias Reichlin has to say.

Prof. KR Julian Chun presents the updated experience from the CCB group with the FARAPULSE PFA System.

Prof. Kars Neven presents an overview of PFA, its history, pre-clinical data, system design, and more.

On-demand online training.

Put your understanding of pulsed field ablation to the test with a guided overview course on the EDUCARE platform — accessible 24/7 from your desktop, laptop, or mobile device.

List of products

Arrhythmia therapy products

Our EP portfolio is at the leading edge of diagnosing and treating heart rhythm disorders.

Icon with envelope

Request a sales representative

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

CAUTION:The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device. or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.This material not intended for use in France.
© 2023 Boston Scientific Corporation or its affiliates. All rights reserved.